Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies

scientific article published on February 1998

Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.7326/0003-4819-128-4-199802150-00005
P698PubMed publication ID9471930

P2093author name stringQuinn TC
Gaydos CA
Howell MR
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectChlamydia trachomatisQ131065
family planningQ1280670
cost-effectiveness analysisQ1754768
P304page(s)277-284
P577publication date1998-02-01
P1433published inAnnals of Internal MedicineQ564416
P1476titleScreening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies
P478volume128

Reverse relations

cites work (P2860)
Q35092226American College of Preventive Medicine practice policy statement: screening for Chlamydia trachomatis
Q37874745Barriers to screening sexually active adolescent women for chlamydia: a survey of primary care physicians.
Q35530159Chlamydia trachomatis diagnostics
Q35531472Chlamydia trachomatis prevalence in men in the mid-west of Ireland
Q34548974Chlamydia trachomatisInfections in Female Soldiers, Israel
Q37869010Clinical management of chlamydia and gonorrhea infection in a county teaching emergency department--concerns in overtreatment, undertreatment, and follow-up treatment success.
Q37865219Comparison of DNA extraction from cervical cells collected in PreservCyt solution for the amplification of Chlamydia trachomatis
Q35529396Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
Q35021415Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies
Q37835246Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women
Q36272418Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails
Q37869842Current Issues in Screening for Chlamydia trachomatis
Q35627542Developments in the screening for Chlamydia trachomatis: a review
Q37614736Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
Q33617158Estimating age-dependent per-encounter chlamydia trachomatis acquisition risk via a Markov-based state-transition model
Q64118387Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of and in Male and Female Urogenital Samples
Q37849297Female genital Chlamydia trachomatis infection: where are we heading?
Q34222251Follow-up, treatment, and reinfection rates among asymptomatic chlamydia trachomatis cases in general practice.
Q35562639High prevalence of genital Chlamydia trachomatis infection in women presenting in different clinical settings in Jamaica: implications for control strategies
Q36059110Just the berries. Diagnosing Chlamydia trachomatis.
Q35528964Low diagnostic accuracy of selective screening criteria for asymptomatic Chlamydia trachomatis infections in the general population
Q35026625Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges.
Q36928670Modelling the effectiveness of chlamydia screening in England
Q35531545Modelling the healthcare costs of an opportunistic chlamydia screening programme
Q35688390Optimizing strategies for population-based chlamydia infection screening among young women: an age-structured system dynamics approach
Q35873375Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae
Q34746935Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens
Q37875570Point-of-entry screening for C. trachomatis In female army recruits. Who derives the cost savings?
Q36314501Prevalence of Chlamydia trachomatis infection among low- and high-risk Filipino women and performance of Chlamydia rapid tests in resource-limited settings
Q35530281Provider willingness to screen all sexually active adolescents for chlamydia
Q36170683Reasons for testing women for genital Chlamydia trachomatis infection in the Calgary region
Q33720510Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014
Q89456457Relationship between Chlamydia Trachomatis Infection with Patency Tubal and Non-Patency Tubal Occurrence in Infertile Women
Q37853880Relative efficiency of chlamydia screening in non-clinical settings in two California counties
Q43427394STD risk assessment and chlamydia screening: what's missing?
Q37837870School-Based Sexually Transmitted Disease Screening: Review and Programmatic Guidance.
Q42756958Screening for Chlamydia trachomatis. The case for screening is made, but much detail remains to be worked out.
Q36491361Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling
Q30986792Screening for chlamydial infection
Q35888108Sexually transmitted diseases and managed care: an inquiry and review of issues affecting service delivery
Q37877139Sexually transmitted diseases in women. Chlamydia trachomatis and herpes simplex infections
Q35433936Sexually transmitted infections in Canada: A sticky situation
Q77856216The Use of Urine and Self-obtained Vaginal Swabs for the Diagnosis of Sexually Transmitted Diseases
Q36170984The laboratory diagnosis of Chlamydia trachomatis infections
Q33666167Use of ligase chain reaction with urine versus cervical culture for detection of Chlamydia trachomatis in an asymptomatic military population of pregnant and nonpregnant females attending Papanicolaou smear clinics
Q37875616Which women should be tested for Chlamydia trachomatis?
Q37862992Women presenting with lower abdominal pain: a missed opportunity for chlamydia screening?

Search more.